Stay updated on Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting an internal/website version change rather than a change to the clinical study record.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated to v3.5.0 and previous revision v3.4.3 removed. This reflects a backend update to the page's versioning rather than changes to study data.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded the final published reference (Eur J Heart Fail, 2025) and removed the online-ahead-of-print citation for the study publications section.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.2 was added. The long notice about government funding lapses and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.5%

Stay in the know with updates to Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.